New drug for the treatment of Secondary Progressive MS has been approved by the FDA.
The discovery of a new subtype of multiple sclerosis that takes a slightly different course in the body could make future treatments more personal.
A promising drug slowed brain shrinkage in progressive multiple sclerosis (MS) by nearly half, according to new research. Very limited therapies are currently available for this disabling form of the disease. Learn more about this therapy.
For most people, it’s better to take drugs for multiple sclerosis early rather than let the disease run its course, according to new treatment guidelines from the American Academy of Neurology.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Temper multiple sclerosis (MS) symptoms and help prevent flare-ups with these five wellness recommendations based on recent scientific research.
Your immune system usually protects you in a process that few of us think about. But sometimes, things go wrong, and it fails. Find out what happens — and why.
The immune system is your body’s internal attack dog against foreign invaders or threats to your health. Find out how it works and how best to keep it healthy.
A drug recently approved to slow the progression of multiple sclerosis (MS) also may help some people in the early stages of the disease to reverse some physical disability, new research suggests.
Most people with MS are able to manage their symptoms and live a normal life, but early detection is key to getting the disease under control.
Even if your MS is well controlled, you still may sometimes wonder whether new or changing symptoms are a cause for concern. Find out what to expect and when you definitely want to call your doctor.